Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Global Blood Therapeutics, Inc. (GBT)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/09/2023 |
SC 13G/A
| FMR LLC reports a 0.4% stake in GLOBAL BLOOD THERAPEUTICS INC |
| 02/14/2022 |
SC 13G/A
| Point72 Asset Management, L.P. reports a 0.3% stake in Global Blood Therapeutics, Inc. |
| 02/14/2022 |
SC 13G/A
| PERCEPTIVE ADVISORS LLC reports a 5.4% stake in Global Blood Therapeutics, Inc. |
| 02/14/2022 |
SC 13G/A
| PRICE T ROWE ASSOCIATES INC reports a 5% stake in Global Blood Therapeutics, Inc. |
| 02/10/2022 |
SC 13G/A
| JANUS HENDERSON GROUP PLC reports a 8.5% stake in Global Blood Therapeutics, Inc. |
| 02/10/2022 |
SC 13G/A
| VANGUARD GROUP INC reports a 9.3% stake in Global Blood Therapeutics Inc. |
| 02/03/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/31/2022 |
SC 13G/A
| BANK OF AMERICA CORP reports a 2.5% stake in Global Blood Therapeutics, Inc. |
| 10/12/2021 |
SC 13G/A
| JANUS HENDERSON GROUP PLC reports a 10.1% stake in Global Blood Therapeutics, Inc. |
| 05/10/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/08/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/08/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/29/2021 |
SC 13G/A
| BlackRock Inc. reports a 6% stake in GLOBAL BLOOD THERAPEUTICS INC |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/07/2020 |
SC 13G/A
| FMR LLC reports a 8.7% stake in GLOBAL BLOOD THERAPEUTICS INC |
| 02/05/2020 |
SC 13G/A
| BlackRock Inc. reports a 8.1% stake in GLOBAL BLOOD THERAPEUTICS INC |
| 01/28/2020 |
SC 13G/A
| WELLINGTON MANAGEMENT GROUP LLP reports a 4.9% stake in Global Blood Therapeutics, Inc. |
| 11/12/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2019 |
SC 13G/A
| HENDERSON GROUP PLC reports a 4.5% stake in Global Blood Therapeutics, Inc. |
| 02/04/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2018 |
SC 13G/A
| Point72 Asset Management, L.P. reports a 0.9% stake in GLOBAL BLOOD THERAPEUTICS, INC. |
| 02/13/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
|
|
|